WallStreetZenWallStreetZen

NASDAQ: APDN
Applied Dna Sciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

APDN past revenue growth

How has APDN's revenue growth performed historically?
Company
-26.43%
Industry
0.71%
Market
14.02%
APDN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
APDN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
APDN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

APDN earnings and revenue history

Current Revenue
$13.4M
Current Earnings
-$9.9M
Current Profit Margin
-74.4%

APDN Return on Equity

Current Company
-126.8%
Current Industry
-53.4%
Current Market
-8.4%
APDN's Return on Equity (-126.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when APDN announces earnings.

APDN Return on Assets

Current Company
-57.7%
Current Industry
6.6%
APDN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

APDN Return on Capital Employed

Current Company
-92.05%
Current Industry
10.7%
APDN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

APDN vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
APDN$13.37M-$8.58M-$9.95M+27.92%N/A
NDRA$0.00-$11.61M-$11.89M-100.00%N/A
GENE$5.64M-$7.71M-$7.63M+111.91%N/A
BIAF$321.49k-$7.04M-$7.24M+12,989.94%N/A
BGLC$10.34M-$2.87M-$3.09M+233.75%N/A
View Top Diagnostic & Research Stocks

APDN earnings dates

Next earnings date
Dec 12, 2023

Applied Dna Sciences Earnings & Revenue FAQ

What were APDN's earnings last quarter?

On Invalid Date, Applied Dna Sciences (NASDAQ: APDN) reported Q3 2023 earnings per share (EPS) of -$0.27, up 2,800% year over year. Total Applied Dna Sciences earnings for the quarter were -$3.59 million. In the same quarter last year, Applied Dna Sciences's earnings per share (EPS) was $0.01.

If you're new to stock investing, here's how to buy Applied Dna Sciences stock.

What was APDN's earnings growth in the past year?

As of Q4 2023, Applied Dna Sciences's earnings has grown year over year. Applied Dna Sciences's earnings in the past year totalled -$9.95 million.

What is APDN's earnings date?

Applied Dna Sciences's earnings date is Invalid Date. Add APDN to your watchlist to be reminded of APDN's next earnings announcement.

What was APDN's revenue last quarter?

On Invalid Date, Applied Dna Sciences (NASDAQ: APDN) reported Q3 2023 revenue of $779.74 thousand up 78.09% year over year. In the same quarter last year, Applied Dna Sciences's revenue was $3.56 million.

What was APDN's revenue growth in the past year?

As of Q4 2023, Applied Dna Sciences's revenue has grown -26.43% year over year. This is 27.14 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 0.71%. Applied Dna Sciences's revenue in the past year totalled $13.37 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.